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Introduction
Psychosocial illness, including depression, is common in people with cardiovascular disease. Depression is particularly common in patients with heart failure (HF) 1 . Probably most patients with HF are depressed by their illness at some time but a meta-analysis suggests that depression affects about a 20% of patients at any time 2 .
For patients with HF, depression is associated with an increased rate of adverse outcomes 2, 3 , such as hospitalization and death. The aggregated risk-estimate derived from 26 studies was an approximately 1.5-fold risk of death in patients with HF if they had depression (3) . However, it can be difficult to disentangle whether depression causes a worse outcome, or merely reflects worse HF or more severe co-morbidity. We aimed to assess the prevalence and consequences of depression in patients admitted to hospital for worsening HF. We analyzed a prospective patient cohort and controlled for common covariates reflecting the severity of both the HF and any comorbidities.
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Methods

Study design
OPERA-HF is an ongoing prospective observational study, enrolling patients hospitalized with worsening heart failure (WHF) to the Hull & East Yorkshire Hospitals NHS Trust, UK. The aim of the study is to gather a holistic view of the patients, their general condition and comorbidities, and to identify predictors of mortality and re-admission to hospital. Clinical and psycho-social data were collected during hospital admission and just prior to discharge. The
Charlson comorbidity index (CCI) was used to assess comorbidity (Appendix A).
Patients had to fulfill all of the following criteria to be included in the study: age >18 years; hospitalization for WHF; treatment with loop diuretics; and at least one of the following:
left ventricular ejection fraction ≤ 40%, left atrial dimension >4.0 cm or NT-ProBNP >400 pg/ml (if in sinus rhythm) or >1200 pg/ml (if in atrial fibrillation 
Depression assessment
Depression was assessed by the Hospital Anxiety and Depression Scale (HADS-D) questionnaire 4 (Appendix B). The HADS-D focuses on questions about depression. The response to each of the 7 questions is graded from 0 to 3, giving a total score that ranges between 0 and 21. A score of 7 or less implies that there is no depression; a score of 8-10 suggests mild
depression; and a score of 11 reflects moderate-to-severe depression 4 . Among 12 studies assessing the HADS-D questionnaire (total N = 2109 patients), a cut point of 8 for the diagnosis of depression had a mean specificity of 0.79 and a mean sensitivity of 0.83 when compared with a 'gold standard' diagnosis using DSM-III/IV or similar codes 5 .
Mortality
All patients enrolled in the study are followed subsequent to discharge. Readmissions and all-cause mortality are automatically recorded in the hospital's IT system. For the present report, the primary outcome of interest was all-cause mortality.
Statistical analysis
We report the baseline characteristics of the patients who participated in the study Univariable and multivariable Cox proportional hazard regression models were used to estimate the association between depression and all-cause mortality. Univariable analysis was performed to assess the relation between variables and outcome, including demographics, clinical assessment, echocardiography and medication. In the multivariable model, we adjusted for all the variables found to predict outcome (P ≤ 0.1) in the univariable analysis. Multiple imputation 6 was used to impute missing data when need. The Kaplan-Meier method was used to estimate survival time and produce a survival curve 7 . All analyses were conducted using R 3.1.3 statistical software (The R Foundation for Statistical Computing, Vienna, Austria). In particular, the R package mice 8 was used for the multiple imputation and the R package survival 9 for the Kaplan-Meier method and the survival analysis.
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Depression assessment
The median HADS-D score amongst the 242 HF patients was 6 (IQR = 3 -9); 153 patients had no (score 0-7), 54 had mild (score 8-10) and 35 had moderate-to-severe (score 11-21) depression, respectively. Patients with moderate-to-severe depression were, on average, in a worse NYHA class, had more likely sinus heart rhythm and were taking more HF medications than those with no depression Table 1 .
Patients were more likely to give high (i.e. worse) scores to the questions "I can laugh and see the funny side of things" and "I feel as if I am slowed down" Table 2 .
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Effect of depression on mortality
The unadjusted rate for all-cause mortality was almost five times higher amongst patients with moderate-to-severe depression compared to patients without depression (HR: 4.9; 95% CI:
2.3 to 10.2; P < 0.001, Table 3a and Figure 1 ). Increasing age (as a continuous variable),
increasing NT-proBNP (continuous), NYHA class IV within 7 days before admission (compared with patients with Class I/II), increasing CCI score, and use of a mineralocorticoid receptor antagonist, beta-blocker and diuretic were all associated with increasing mortality. We therefore corrected for these characteristics in the multivariable analysis Table 3b ). Moderate-tosevere depression remained a significant predictor of all-cause mortality (HR: 3.0; 95% CI: 1.3 to 7.0; P < 0.05) along with NT-proBNP (HR: 1.7; 95% CI: 1.1 to 2.8; P < 0.05) and NYHA class IV (HR: 1.2; 95% CI: 1.0 to 4.6; P < 0.1). Further details on the association between the covariates and the outcome are provided in Table 4 (Appendix D).
Discussion
Amongst patients admitted to hospital with worsening heart failure, the presence of moderate to severe depression is a strong predictor of mortality subsequent to discharge, even after correcting for potential confounders. This is consistent with evidence suggesting that depression predicts mortality amongst patients with chronic HF 2,3 but the relationship may be even stronger for those admitted to hospital with worsening heart failure.
Whether the association between depression and mortality is causal and, if so, whether targeting this link could improve prognosis remains uncertain. Pessimism and depression may have biological effects that adversely affect prognosis 10 . Alternatively, depression may reduce adherence to life-style advice and heart failure medications leading to a worse prognosis 11, 12 .
Health care professionals might be unconsciously less attentive to depressed patients. Finally, it is possible that we did not identify and measure some key prognostic variables; some patients may be depressed because they not only feel sicker but are indeed sicker. The clinical reality is that all of the above are probably relevant to different patients at different times. Teasing out which is the most important for an individual patient may be difficult.
It is unclear whether the recognition and management of depression might improve patient outcomes. Randomized trials of drug intervention with selective serotonin re-uptake inhibitors have been disappointing 13, 14 . Interestingly, many patients admitted to hospital with worsening heart failure report good quality of life after discharge 15 interventions, such as cognitive behavioral therapy, use of self-management plans delivered by community health care teams or by tele-monitoring might be effective alternatives to drug therapy 16 . Tackling the problems that depression causes rather than depression itself could also be important; a diagnosis of depression should heighten awareness of the need for support, advice and encouragement of adherence.
Mild depression was not strongly associated with mortality in either the univariable or multivariable models. This may reflect the attributes of the HADS score; several questions could reflect the severity of functional impairment due to HF itself rather than depression. For instance, one question asks the patient to rate this statement "I feel as if I am slowed down"; most patients gave themselves poor scores on this question, which could be interpreted as the inability to exercise due to heart failure: however, it leads to patients being given a HADS score suggesting mild depression.
Most patients gave themselves a worst-rank score for the statement "I can laugh and see the funny side of things". For other questions, there was a wider distribution of scores. It is not clear that the relatively complex questionnaires currently used to assess mood and quality of life are superior to single, simple, direct, intuitive questions in detecting important depression ("Are you depressed? If so, how badly does this affect you?") or assessing well-being ("On a scale of 1-10 how well are you today?"); single questions are easy to administer and may be more efficient, although they may need to be interpreted in the context of the patients situation (for example, recent near-death experience, worsening heart failure or stable CHF) 17 . Indeed,
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11 responses to just two-questions (PHQ-2) appears to identify patients with depression fairly accurately compared to more complex instruments 18 .
Other Limitations. The study is relatively small, with a modest number of events, but it is one of the first in patients hospitalized with WHF. The diagnosis of depression was made with a tool that does not give the same diagnostic certainty as DSM-III/IV or similar codes. The tool was only administered once, and we may have missed changes in mood during or after hospitalization. The HADS uses some colloquial language which may not be understood by patients from different backgrounds.
Conclusion.
Moderate to severe depression is strongly associated with mortality in the year following discharge after a HF admission to hospital. The association is independent of HF severity and other comorbidity. New strategies are required to improve the recognition of depression and to target those with persistent problems who might benefit from intervention. 
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Figure legends
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Appendices
A. Charlson Comorbidity Index (CCI)
Comorbidity is assessed by Charlson Comorbidity Index (CCI) 19 . CCI is calculated during hospitalization by assigning to certain comorbidities a weighted value.
Myocardial infarction, congestive heart failure, peripheral vascular disease, dementia, cerebrovascular disease, chronic pulmonary disease, connective tissue disease, ulcer disease, mild liver disease, diabetes.
Hemiplegia, moderate or severe renal disease, diabetes with end organ damage, any tumor, leukemia, lymphoma.
Moderate or severe liver disease. In Table 4 the results of the univariable and multivariable Cox regression analysis are provided.
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